19-48015969-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022142.5(ELSPBP1):c.285A>C(p.Leu95Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022142.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELSPBP1 | NM_022142.5 | c.285A>C | p.Leu95Phe | missense_variant | 4/7 | ENST00000339841.7 | NP_071425.3 | |
ELSPBP1 | XM_017027130.2 | c.420A>C | p.Leu140Phe | missense_variant | 4/7 | XP_016882619.1 | ||
ELSPBP1 | XM_047439213.1 | c.420A>C | p.Leu140Phe | missense_variant | 4/6 | XP_047295169.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELSPBP1 | ENST00000339841.7 | c.285A>C | p.Leu95Phe | missense_variant | 4/7 | 1 | NM_022142.5 | ENSP00000340660.2 | ||
ELSPBP1 | ENST00000593782.1 | c.75A>C | p.Leu25Phe | missense_variant | 1/4 | 5 | ENSP00000472960.1 | |||
ELSPBP1 | ENST00000596043.5 | c.147A>C | p.Leu49Phe | missense_variant | 3/5 | 3 | ENSP00000470903.1 | |||
ELSPBP1 | ENST00000597519.5 | c.71-6201A>C | intron_variant | 3 | ENSP00000471690.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.285A>C (p.L95F) alteration is located in exon 4 (coding exon 3) of the ELSPBP1 gene. This alteration results from a A to C substitution at nucleotide position 285, causing the leucine (L) at amino acid position 95 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.